Welcome, Guest
Username Password: Remember me
Science & Technology
  • Page:
  • 1

TOPIC: Dept of Health UK, Corporate Plan - Research & Innovation

Dept of Health UK, Corporate Plan - Research & Innovation 1 week ago #1

(NL) Department of Health corporate plan 2013 to 2014

Updated 3 March 2014

Better Health and Wellbeing for all

We will work to improve health outcomes and reduce premature mortality and health inequalities. We will ensure we have the capabilities & policies in place to address threats to public health, strengthen our public health system and promote health and wellbeing.

Improve and promote health and wellbeing throughout the whole course of life and reduce the burden of conditions associated with poor lifestyles such as obesity, smoking, drug misuse and harmful alcohol consumption.

In particular, we will:

•reduce numbers of people dying prematurely by improving prevention, screening and early diagnosis (to enable more effective treatment), and thereby improve mortality rates for the big killer diseases, in absolute terms and relative to the best in Europe. (PHD)

•deliver the key policy priorities for health and wellbeing in the areas of long-term conditions, premature mortality and oral health, and align the Outcomes Frameworks for Social Care, Public Health and the NHS so that they improve joint working and outcomes for the people of England. (PHD, SCLGCP & FN)

•improve and promote health and wellbeing throughout the whole course of life and reduce the incidence of conditions associated with smoking, drug misuse, harmful alcohol consumption, obesity, poor diet, lack of physical activity, poor sexual health and violence (PHD & SCLGCP)

•harness the potential of innovations in medical science such as genetics, embryology, organs and stem cells, including the Prime Minister’s commitment to sequence 100,000 genomes. (PHD)

•commission relevant and timely research evidence through the National Institute for Health Research (NIHR) and the Policy Research Programme, to meet the needs of patients, professionals, the public and policy makers (RDD)

•make it faster and easier to initiate and deliver research by helping the NHS to improve research management performance and speeding up the availability of new interventions for patients and the public (RDD)

•improve health outcomes for people with mental health problems through the continued development of the “No Health Without Mental Health” strategy and effective stewardship of the Mental Health Act. (SCLGCP)

•improve health outcomes for children and young people in line with the Children and Young People’s Health Outcomes Pledge and the system’s response to the Forum’s recommendations. (SCLGCP)

•help children to make the best start in life through the further development of the Information Service for Parents, offering multimedia advice on how babies & children develop, antenatal education and advice on breastfeeding & immunisations, and by delivery of the National Health Visitor Programme and the Family Nurse Partnership Programme to increase capacity and transform services. (SCLGCP & PHD)

•improve diagnosis through overseeing screening programmes, including the piloting of bowel scope screening. (PHD)

Create and sustain a new public health system which rebalances our approach to health, drawing together national leadership with local delivery, and a new sense of community and social responsibility.

We will:
•support the new balance of public health responsibilities between Local Government, PHE, DH and the NHS. (PHD)
•strengthen research on chronic conditions and public health across NIHR programmes, including through new Collaborations for Leadership in Applied Health Research and Care, and on in vitro diagnostics through new Diagnostic Evidence Co-operatives. (RDD)

Protect the health of the population, by ensuring we have the right policies and capabilities to protect people from a range of health threats such as those associated with pandemic influenza and terrorist attack. In particular we will:

•take urgent action to help slow down the development of antimicrobial resistance by leading work to encourage more responsible use of antibiotics in this country and internationally , and working with industry to encourage the development of new antibiotics. (PHD)
•provide strategic oversight to the development and implementation of new national vaccination programmes – seasonal flu, rotavirus and shingles. (PHD)
•protect the health of the population, by ensuring we have the right policies and capabilities to protect people from a range of health threats such as those associated with pandemic influenza and terrorist attack. (PHD)

Better Care for all

We will work to improve the quality of care for all people using services, including reforming social care, working with the NHS to strengthen people’s ability to make meaningful choices about their care and treating people with dignity and respect.

Focus on getting quality, safety and dignity right every time in care services. In particular we will:
•deliver the government’s response to the Mid Staffordshire NHS Foundation Trust Public Inquiry recommendations, working jointly with other bodies, to help increase compassion and dignity in the NHS. (SER, RDD & FN)
•deliver the Secretary of State’s Care Priority to ensure that the quality of care is as important as the quality of treatment. (SER)
•deliver a system of medical revalidation that will enable delivery of key benefits around improved quality of care, safety, efficiency and public confidence. (SER)
•improve the quality of life for those with dementia and their carers by improving health and care, research and “dementia friendly” communities and by announcing the outcome of a joint ESRC/NIHR call for research on living well with dementia and publishing the progress against the PM Challenge on Dementia. (RDD & SCLGCP)
•support delivery of national nursing strategy Compassion in Practice. (PHD)

Reform the system of social care. In particular we will:
•reform the system of adult social care to implement the White Paper & improve the legal framework, including a new funding system, to drive improved outcomes for service users and their carers, and ensure fit for purpose outcome-focused national datasets (SCLGCP)
•deliver ministers’ priorities for an efficient and effective NHS estate and facilities, particularly around supporting patient safety, care and dementia, with a focus on the NHS Constitution’s commitment to patients, staff and the wider public (IGO)
•lead the programme to improve care and support available during pregnancy, birth and the start of life. (SCLGCP)
•oversee the programme of action in response to Transforming Care – implement the Winterbourne View Review so that services for people with challenging behaviour are transformed and review the statutory autism strategy (SCLGCP)
•provide strategic direction in modernising the health and care workforce to ensure that the right skills, values, behaviours and training, is available in the right numbers, to support the delivery of high quality care and health improvement (SER & SCLGCP)

Put users and carers at the centre of decision making, with care integrated around their needs, to include embedding shared decision-making as the norm. In particular we will:
•ensure that issues raised by individual patients, their carers and representatives about the care they receive are listened to and acted upon, so as to improve an organisation’s ability to improve its standards and its culture of caring (SER)

Improve the outcomes of care services, and support innovation. In particular we will:
•improve outcomes and experience and ensure better coordinated care by publishing the Common Purpose Framework with key national partners (SCLGCP, FN)
•improve the quality and use of technology and information in the health and care system including development of a single portal for patients to see comparative data across the system (SER)
•help people stay independent, by maximising well-being and improve health outcomes through strong leadership and strategic partnerships across nursing, midwifery, health visiting & allied health professions, and grow & transform the health visitor service (PHD)

Better Value for all

We will work to increase productivity and ensure better value for money for the taxpayer, including reducing bureaucracy and supporting the NHS to save up to £20 billion to reinvest in frontline services.

Contribute to economic growth. In particular we will:
•encourage growth, value for money and better regulation by supporting delivery of national QIPP procurement work, negotiating new arrangements for branded medicines pricing, delivering the Health and Life Sciences Plan for Growth and reducing bureaucracy and costs to the business and addressing the Red Tape Challenge (FN)
•ensure England maximises its share of life sciences research collaborations and investment, contributing to the economic growth of the country, by supporting a vibrant, world-class NHS platform for research investment by the life-sciences industry and major public sector research funders, and life-sciences sponsorship and its strategy implementation. (RDD & FN)
•support growth and value for money by managing the commercial investment decisions, supporting international investment through the “golden thread”, and achieving value for money, including by managing financial implications of EU/EEA membership (PHD & FN)

Improve efficiency and reduce bureaucracy. In particular we will:
•launch and deliver a Baseline Review to reduce costs across the system (FN)
•lead strategic financial planning and discharge the Department’s financial management responsibilities effectively and efficiently by negotiating the spending settlement for financial year 2015 to 2016, developing the financing and failure regime for NHS providers, and delivering unqualified annual statutory accounts for the Department (FN)
•reform the NHS employment package to deliver the Secretary of State’s priority for high quality, safe and compassionate care, including the development and implementation of pay and pension policies, which support the recruitment and retention of skilled staff right across the NHS and independent sectors (SER)
•ensure effective implementation of reform to education and training funding, with tariffs providing greater fairness, transparency and efficiency (SER)
•review and deliver the Bureaucracy and Regulatory Review’s recommendations following the report by the NHS Confederation (SER)
•maximise the benefits available from new technology and information, including implementation of the Information Strategy, leading Secretary of State’s priority work and building the capability of the new Health and Social Care Information Centre. (SER)
•support increases in speed and cost effectiveness of trial set up in the NHS by publishing outcomes against a 70 day benchmark (70 days or less from the time a provider of NHS services receives a valid research application to the time when that provider recruits the first patient for that study) (RDD)
•commission an evaluation of the “Innovation, Health and Wealth” Strategy, to assess the effectiveness of actions to promote the spread of innovation in the NHS (RDD)

Successful Change

We will work to ensure a smooth and successful transition of the health and social care system, developing and articulating our common purpose to align our work across all organisations, and establishing a framework that can realise the benefits for the health and care system.

Manage the transition to the new health and care system architecture. In particular we will:

•lead the coherent design of, and transition to, the new health and care system through legislation to reform the Care and Support System and implement the Health and Social Care Act, publishing the Common Purpose Framework for integrated care, and ensure effective management of the portfolio of ex-PCT and SHA property (SCLGCP & FN)

•lead the transformation work in the Department of Health so it can fully deliver its new role, including clearly defining and communicating the Department’s role in the system, and deliver wider Civil Service Reform changes (IGO)

•programme manage the completion of the transition & legacy work, which the Department of Health and all new bodies in the system, will need to carry out during financial year 2013 to 2014, culminating in a fully functioning, efficient and effective new health & care system (IGO)

•ensure there are proper governance and accountability arrangements in place across the new health and social care system so that DH and Arm’s Length Bodies meet their public and Parliamentary accountabilities (SER)

•refresh the Mandate and establish effective accountability arrangements for the NHS England (NHSE), support NHSE and Monitor as they take on accountability for the NHS payment system, in particular by developing the tariff for financial year 2014 to 2015 (FN)

•support primary legislation to establish the Health Research Authority as a non-Departmental public body in order to give it even greater stability and independence (RDD)

Establish the framework for beginning to realise the benefits of reform. In particular we will:

•support the development of Health Education England and the Local Education and Training Boards and establish effective accountability arrangements (SER)

•support Health and Wellbeing Boards to realise their potential, working with partners to ensure that the boards can work effectively locally to improve services and outcomes (SCLGCP)

•support the functions of Public Health England by establishing NIHR Health Protection Research Units in 12 priority topics (RDD)

•support, monitor, oversee and drive delivery and overall implementation of the Information Strategy for Health and Social Care, ensuring alignment with the Government Digital Strategy where appropriate (SER)

•support others to meet their statutory duty to promote research by continuing to work as appropriate with the NHS England, Clinical Commissioning Groups and Monitor (RDD)

•co-ordinate the department’s response to Open Public Services and refresh the Outcomes Framework (FN)

•ensure a more transparent process of Death Certification is put in place, with robust safeguards and a unified system of certification and payment; independent advice from medical examiners, improved quality of data (PHD)

Our Partners

We will work to develop stronger partnerships – working across government, with our external stakeholders and establishing effective ways of working with our new partnership organisations.

Build partnerships with our stakeholders. In particular we will:
•enable the voice of the Voluntary and Community Sector and develop our understanding of their role in the health and social care system (SCLGCP)
•provide leadership, stewardship and alignment of communications activity across the health and care system. (SER)
•work through our sponsorship of Healthwatch England to build an effective local network that empowers local people and communities to present their views and experiences to feed into local and national policy decisions about care services. (SCLGCP)

Sponsor our arm’s length bodies (ALBs) effectively. We will develop excellent relationships with our ALBs and executive agencies. In particular we will:
•implement and manage an effective operating model for sponsorship of NHS England (FN)
•work effectively with local government, NHSE and Public Health England (PHE) to assure the effective public health and adult social care contribution to improved outcomes for individuals and communities (PHD & SCLGCP)
•build and embed effective assurance and sponsorship systems and capabilities within the Department of Health, which support and assure the new arms length bodies and build common purpose across the wider health and care system. (IGO)
•sponsor and develop relationships with our Arm’s Length Bodies, including Health Education England (HEE), Health Research Authority (HRA), NHS Litigation Authority, NHS Business Services Authority (NHS BA), Monitor, National Institute for Health and Care Excellence (NICE), NHS Trust Development Authority (NHS TDA), Medicines & Healthcare products Regulatory Agency (MHRA), NHS Blood & Transplant (NHSBT), Human Fertilisation & Embryology Authority (HFEA), Human Tissue Authority (HTA) and Care Quality Commission (CQC) to provide appropriate stewardship and enable them to flourish (SER, PHD, FN & RDD)
•Lead the setup of Health and Social Care Information Centre (HSCIC) to establish its role as the main information and technology partner within the health and care sector (SER)

Assist other government departments. We will build stronger, mutually supportive relationships with other government departments – with them supporting our goals, and us supporting the wider goals of the Government as a whole. In particular we will:
•lead effectively and seamlessly for the UK Government on health issues overseas, including in the EU, WHO, ensuring other government departments (OGDs) and civil society have full opportunity to present their views and influence the UK delegations (PHD)
•establish a network of partnership engagement across government to share learning and pool resources to improve the way government works with others (SER)

(Nusrat Latif)
Last Edit: 16 hours, 28 minutes ago by Nusrat Latif.
  • Page:
  • 1
Time to create page: 0.19 seconds